Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P Murphy

Showing results (681-690 of 751) with videos related to

Pageof 76
Sort By:
Cancer Research|April 1, 1983
LNCaP model of human prostatic carcinomaJ S Horoszewicz, S S Leong, E Kawinski, et al.
Cancer|February 1, 1993
American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigenC Mettlin, G P Murphy, P Ray, et al.
The American Surgeon|June 1, 1970
Treatment of baboon renal allotransplants with subcellular kidney cell fractionsG P Murphy, H D Brede, H W Weber, et al.
The Journal of Surgical Research|November 1, 1970
The renal and cardiodynamic effects of prostaglandins (PGE1, PGA1) in renal ischemiaG P Murphy, V E Hesse, J L Evers, et al.
Seminars in Oncology|June 1, 1976
Chemotherapy of advanced prostatic cancer by the National Prostatic Cancer GroupG P Murphy, J Saroff, J R Joiner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Expression and purification of prostate-specific membrane antigen in the baculovirus expression system and recognition by prostate-specific membrane antigen-specific T cellsP A Lodge, R A Childs, S J Monahan, et al.
The Journal of Urology|December 1, 1975
Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized studyW W Scott, D E Johnson, J E Schmidt, et al.
Cancer Research|December 1, 1980
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassayM Kuriyama, M C Wang, L D Papsidero, et al.
Journal of the National Cancer Institute|February 1, 1986
Relative reliability of five serially measured markers for prognosis of progression in prostate cancerC S Killian, L J Emrich, F P Vargas, et al.
Cancer|July 1, 1997
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patientsT H Douglas, T O Morgan, D G McLeod, et al.
Pageof 76

Showing results (681-690 of 751) with videos related to

Sort By:
Pageof 76
Cancer Research|April 1, 1983
LNCaP model of human prostatic carcinomaJ S Horoszewicz, S S Leong, E Kawinski, et al.
Cancer|February 1, 1993
American Cancer Society--National Prostate Cancer Detection Project. Results from multiple examinations using transrectal ultrasound, digital rectal examination, and prostate specific antigenC Mettlin, G P Murphy, P Ray, et al.
The American Surgeon|June 1, 1970
Treatment of baboon renal allotransplants with subcellular kidney cell fractionsG P Murphy, H D Brede, H W Weber, et al.
The Journal of Surgical Research|November 1, 1970
The renal and cardiodynamic effects of prostaglandins (PGE1, PGA1) in renal ischemiaG P Murphy, V E Hesse, J L Evers, et al.
Seminars in Oncology|June 1, 1976
Chemotherapy of advanced prostatic cancer by the National Prostatic Cancer GroupG P Murphy, J Saroff, J R Joiner, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 15, 1999
Expression and purification of prostate-specific membrane antigen in the baculovirus expression system and recognition by prostate-specific membrane antigen-specific T cellsP A Lodge, R A Childs, S J Monahan, et al.
The Journal of Urology|December 1, 1975
Chemotherapy of advanced prostatic carcinoma with cyclophosphamide or 5-fluorouracil: results of first national randomized studyW W Scott, D E Johnson, J E Schmidt, et al.
Cancer Research|December 1, 1980
Quantitation of prostate-specific antigen in serum by a sensitive enzyme immunoassayM Kuriyama, M C Wang, L D Papsidero, et al.
Journal of the National Cancer Institute|February 1, 1986
Relative reliability of five serially measured markers for prognosis of progression in prostate cancerC S Killian, L J Emrich, F P Vargas, et al.
Cancer|July 1, 1997
Comparison of serum prostate specific membrane antigen, prostate specific antigen, and free prostate specific antigen levels in radical prostatectomy patientsT H Douglas, T O Morgan, D G McLeod, et al.
Pageof 76